These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31833441)

  • 1. Chronic Obstructive Pulmonary Disease as a Predictor of Cardiovascular Risk: A Case-Control Study.
    Khanji MY; Stone IS; Boubertakh R; Cooper JA; Barnes NC; Petersen SE
    COPD; 2020 Feb; 17(1):81-89. PubMed ID: 31833441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.
    Gelinas JC; Lewis NC; Harper MI; Melzer B; Agar G; Rolf JD; Eves ND
    Exp Physiol; 2017 Nov; 102(11):1548-1560. PubMed ID: 28857336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
    Bhatt SP; Dransfield MT; Cockcroft JR; Wang-Jairaj J; Midwinter DA; Rubin DB; Scott-Wilson CA; Crim C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():351-365. PubMed ID: 28176907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling.
    Weir-McCall JR; Liu-Shiu-Cheong PS; Struthers AD; Lipworth BJ; Houston JG
    Eur Radiol; 2018 Aug; 28(8):3464-3472. PubMed ID: 29488084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial.
    John ME; Cockcroft JR; McKeever TM; Coward WR; Shale DJ; Johnson SR; Thornton JG; Harrison TW; Knox AJ; Bolton CE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():211-21. PubMed ID: 25673981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disconnection of pulmonary and systemic arterial stiffness in COPD.
    Weir-McCall JR; Liu-Shiu-Cheong PS; Struthers AD; Lipworth BJ; Houston JG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1755-1765. PubMed ID: 29881265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular benefits from standard pulmonary rehabilitation are related to baseline exercise tolerance levels in chronic obstructive pulmonary disease.
    Moore LE; Byers BW; Fuhr DP; Wong E; Bhutani M; Stickland MK
    Respir Med; 2017 Nov; 132():56-61. PubMed ID: 29229106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airflow obstruction was associated with elevation of brachial-ankle pulse wave velocity but not ankle-brachial index in aged patients with chronic obstructive pulmonary disease.
    Chen R; He W; Zhang K; Zheng H; Lin L; Nie R; Wang J; Huang H
    Atherosclerosis; 2015 Sep; 242(1):135-40. PubMed ID: 26188536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of arterial stiffness and wave reflections in chronic obstructive pulmonary disease: the contribution of lung hyperinflation and a comparison of techniques.
    Stone IS; John L; Petersen SE; Barnes NC
    Respir Med; 2013 Nov; 107(11):1700-8. PubMed ID: 23920329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function.
    Spilling CA; Bajaj MK; Burrage DR; Ruickbie S; Thai NJ; Baker EH; Jones PW; Barrick TR; Dodd JW
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1855-1866. PubMed ID: 31686798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chronic Obstructive Pulmonary Disease in Heart Failure With Preserved Ejection Fraction.
    Jain S; Obeid MJ; Yenigalla S; Paravathaneni M; Gadela NV; Singh G; Kulkarni V; Kondaveety S; Gade KC; Lee J; Kulick-Soper CM; Sanchez N; Satija V; Hashmath Z; Zamani P; Akers S; Chirinos JA
    Am J Cardiol; 2021 Jun; 149():47-56. PubMed ID: 33757785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Systemic and Pulmonary Vascular Dysfunction in COPD.
    Piccari L; Del Pozo R; Blanco I; García-Lucio J; Torralba Y; Tura-Ceide O; Moises J; Sitges M; Peinado VI; Barberà JA
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2037-2047. PubMed ID: 32904646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial stiffness measured via carotid femoral pulse wave velocity is associated with disease severity in COPD.
    Cinarka H; Kayhan S; Gumus A; Durakoglugil ME; Erdogan T; Ezberci I; Yavuz A; Ozkaya S; Sahin U
    Respir Care; 2014 Feb; 59(2):274-80. PubMed ID: 23821765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease.
    John M; McKeever TM; Haddad MA; Hall IP; Sayers I; Cockcroft JR; Bolton CE
    Chron Respir Dis; 2016 Aug; 13(3):247-55. PubMed ID: 26965223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid arterial stiffness in patients with chronic obstructive pulmonary disease.
    Albu A; Fodor D; Bondor C; Suciu O
    Acta Physiol Hung; 2011 Jun; 98(2):117-27. PubMed ID: 21616770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes.
    Swoboda PP; Erhayiem B; Kan R; McDiarmid AK; Garg P; Musa TA; Dobson LE; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
    Cardiovasc Diabetol; 2018 Mar; 17(1):35. PubMed ID: 29506523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
    Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
    J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.
    Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal and reference values for cardiovascular magnetic resonance-based pulse wave velocity in the middle-aged general population.
    van Hout MJ; Dekkers IA; Westenberg JJ; Schalij MJ; Widya RL; de Mutsert R; Rosendaal FR; de Roos A; Jukema JW; Scholte AJ; Lamb HJ
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):46. PubMed ID: 33866975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.
    Phillips DB; Steinback CD; Collins SÉ; Fuhr DP; Bryan TL; Wong EYL; Tedjasaputra V; Bhutani M; Stickland MK
    J Physiol; 2018 Aug; 596(15):3233-3244. PubMed ID: 29528117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.